There was only a 1 percent increase—from 5 to 6 percent—in teachers who said they receive continuous PD on generative AI. “We’re in the early stages of AI adoption in K-12. Our first priority is to ...
Spur Therapeutics today announced that it has selected a lead development candidate in its gene therapy program for a genetically defined subset of Parkinson’s disease characterized by mutations in ...